Skip to main content
Log in

Clinical trials report

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schwartz GG, Olsson AG, Ezekowitz MD, et al.: Effects of ator-vastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711–1718.

    Article  PubMed  CAS  Google Scholar 

  2. Sacks FM: Lipid-lowering therapy in acute coronary syndromes. JAMA 2001, 285:1758–1760.

    Article  PubMed  CAS  Google Scholar 

  3. Brown BG, Zhao XQ, Chait A, et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583–1592.

    Article  PubMed  CAS  Google Scholar 

  4. Freedman JE: Antioxidant versus lipid-altering therapy--some answers, more questions. N Engl J Med 2001, 345:1636–1637.

    Article  PubMed  CAS  Google Scholar 

  5. Rubins HB, Robins SJ, Collins D, et al.: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999, 341:410–418.

    Article  PubMed  CAS  Google Scholar 

  6. Rader DJ: A new feature on the cholesterol-lowering landscape. Nat Med 2001, 7:1282–1284.

    Article  PubMed  CAS  Google Scholar 

  7. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23–33.

  8. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7–22.

  9. Hutchison SJ, Reitz MS, Sudhir K, et al.: Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension 1997, 29:1186–1191.

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, P.W.F. Clinical trials report. Curr Cardiol Rep 4, 485–487 (2002). https://doi.org/10.1007/s11886-002-0111-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-002-0111-8

Keywords

Navigation